Literature DB >> 15084569

Adjunctive treatment in patients treated with thrombolytic therapy.

M A Brouwer1, N Clappers, F W A Verheugt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15084569      PMCID： PMC1768201          DOI： 10.1136/hrt.2003.019877

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  15 in total

1.  Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences.

Authors:  S G Ellis; E R Da Silva; C M Spaulding; M Nobuyoshi; B Weiner; J D Talley
Journal:  Am Heart J       Date:  2000-06       Impact factor: 4.749

Review 2.  Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.

Authors:  R Collins; R Peto; C Baigent; P Sleight
Journal:  N Engl J Med       Date:  1997-03-20       Impact factor: 91.245

3.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

4.  Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.

Authors: 
Journal:  Lancet       Date:  2001-08-25       Impact factor: 79.321

5.  Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study.

Authors:  Eric Bonnefoy; Frédéric Lapostolle; Alain Leizorovicz; Gabriel Steg; Eugène P McFadden; Pierre Yves Dubien; Simon Cattan; Eric Boullenger; Jacques Machecourt; Jean-Micel Lacroute; Jean Cassagnes; François Dissait; Paul Touboul
Journal:  Lancet       Date:  2002-09-14       Impact factor: 79.321

6.  Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour.

Authors:  E Boersma; A C Maas; J W Deckers; M L Simoons
Journal:  Lancet       Date:  1996-09-21       Impact factor: 79.321

7.  Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

Authors:  Frans Van de Werf; Diego Ardissino; Amadeo Betriu; Dennis V Cokkinos; Erling Falk; Keith A A Fox; Desmond Julian; Maria Lengyel; Franz-Josef Neumann; Witold Ruzyllo; Christian Thygesen; S Richard Underwood; Alec Vahanian; Freek W A Verheugt; William Wijns
Journal:  Eur Heart J       Date:  2003-01       Impact factor: 29.983

8.  Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial.

Authors:  C B Granger; J Hirsch; R M Califf; J Col; H D White; A Betriu; L H Woodlief; K L Lee; E G Bovill; R J Simes; E J Topol
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

9.  Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

10.  Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group.

Authors: 
Journal:  Circulation       Date:  1998-06-09       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.